Metabolic and Bariatric Surgery and Change in the AI-ECG–Derived Biological-Age Gap: A Longitudinal Cohort Study

Biological age acceleration and mortality risk among U.S. adults with cardio-kidney-metabolic syndrome, stages 0–3

This study aims to evaluate the associations of Klemera-Doubal Method Biological Age Acceleration (KDM-BAA) and Phenotypic Age Acceleration (PAA) with all-cause and cause-specific mortality in U.S. adults with Cardio-Kidney-Metabolic (CKM) syndrome stages 0–3 and to establish risk prediction models. Data were obtained...

Nutritional and Metabolic Trajectories up to 10 Years After Metabolic and Bariatric Surgery: A Tertiary-Centre Retrospective Longitudinal Cohort Study

Within a structured service with high supplement compliance, frank deficiency was uncommon for most markers, and these findings support indefinite, systematic nutritional surveillance after MBS.

Short-Term Changes in General and Central Adiposity and Subsequent Cardiometabolic Risk in Japanese Adults Undergoing Routine Health Screening.

Increases in BMI and WHtR were consistently associated with higher risks of hypertension, dyslipidemia, hyperuricemia, hyperuricemia, and early CKM stage progression across baseline body size categories.

Preoperative Magnetic Resonance Imaging-Derived Adiposity Profiling and Cardiometabolic Remodeling After Metabolic and Bariatric Surgery

Bariatric surgery and risk of dementia and Parkinson's disease in patients with obesity.

OBJECTIVE We aimed to evaluate the association between bariatric surgery (BS) and the incidence of dementia and Parkinson's disease. To assess consistency with established benefits of BS, we examined its association with cardiovascular disease, obesity-associated cancers, and all-cause mortality. METHODS We conducted...

Biological age acceleration and cardiovascular–kidney–metabolic syndrome progression: evidence from UK Biobank and NHANES

Abstract Objective: We examined associations of biological age acceleration with cardiovascular–kidney–metabolic (CKM) syndrome progression and baseline stage burden. Methods: Longitudinal analyses included 326,218 UK Biobank participants, and cross-sectional analyses included 5,228 NHANES adults. PhenoAge and KDMAge a...